By Matt Lamers
In buying a chunk of the world’s largest medical cannabis company, global alcohol giant Constellation Brands substantiated the marijuana industry as both a threat and opportunity for alcohol, pharmaceutical and tobacco companies, analysts and executives said.
In short, the development signals that more deals could be on the horizon – particularly in Canada.
New York-based Constellation Brands – which owns, distributes and markets 100 beer, wine and spirits brands, including Corona and Robert Mondavi – will acquire 9.9% of Smiths Falls, Ontario-based Canopy Growth for 245 million Canadian dollars ($190 million), plus options to
The post Constellation’s purchase of Canopy stake is ‘transformative,’ portends further investments appeared first on Marijuana News.